NCT07302295

Brief Summary

In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24. Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20). Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population. The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,500

participants targeted

Target at P75+ for not_applicable

Timeline
10mo left

Started Dec 2025

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Dec 2025Mar 2027

First Submitted

Initial submission to the registry

November 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Expected
Last Updated

December 24, 2025

Status Verified

November 1, 2025

Enrollment Period

4 months

First QC Date

November 24, 2025

Last Update Submit

December 10, 2025

Conditions

Keywords

suicidepediatricscovid-19

Outcome Measures

Primary Outcomes (1)

  • Demographic and diagnostic characteristics

    The following demographic and diagnostic characteristics will be collected in aggregate form for the entire population of children and adolescents who engaged in suicidal behavior during the health crisis and in the two preceding years: * Age, gender, place of residence, * ICD-10 diagnosis and referral, * Type of suicidal behavior (ideation, self-harm, suicide attempt), * Periods of social restrictions (lockdown, curfew, vaccine pass).

    Baseline

Secondary Outcomes (6)

  • Number of patients aged 8-17 and 11month admitted to pediatric emergency

    Baseline

  • Psychopathological and socio-economic characteristics

    Baseline

  • Scores to CRIES

    Up to 3 months

  • CAS scale

    Up to 3 months

  • Qualitative interview

    Up to 3 months

  • +1 more secondary outcomes

Study Arms (3)

Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1)

EXPERIMENTAL

* Name : Group 1 * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022. * Age ≥ 8 years old and \< 18 years old between 2020 and 2022.

Other: Aggregated data collection

Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b)

EXPERIMENTAL

* Name : Group 1b * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents * Age ≥ 8 years old and \< 18 years old between 2020 and 2022 for subjects. * One or both parents * Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects). * Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.

Other: Data collection and qualitative interview

Subjects control with suicidal behaviors before the health crisis (Group 2).

EXPERIMENTAL

* Name: group 2 * Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region * Age ≥ 8 years old and \< 18 years old between 2018 and 2019

Other: Aggregated data collection

Interventions

The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.

Subjects control with suicidal behaviors before the health crisis (Group 2).Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1)

The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.

Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b)

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • The population (subjects and controls) will be divided into age categories:
  • Pre-adolescents (≥ 8 years and \< 11 years)
  • Adolescents (≥ 11 years and \< 15 years)
  • Older adolescents (≥ 15 years and \< 18 years)
  • Subjects with suicidal behavior during the health crisis (Group 1):
  • Age \> 8 years and \< 18 years during the period 2020 to 2022.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
  • Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):
  • Age \> 8 years and \< 18 years during the period 2020 to 2022.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
  • Randomly selected from the population of Group 1.
  • For whom the parent(s) and/or the subject have signed informed consent.
  • Controls with suicidal behavior before the health crisis (Group 2):
  • Age \> 8 years and \< 18 years during the period 2018 to 2019.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

You may not qualify if:

  • \- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):
  • Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.
  • Controls with Suicidal Behavior before the Health Crisis (Group 2):
  • Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
  • Intercurrent illness with a life expectancy of less than 24 hours.
  • For Group 1:
  • Pregnant, postpartum, or breastfeeding women.
  • Persons deprived of liberty by judicial or administrative decision.
  • Adults subject to a legal protection measure (guardianship, curatorship).
  • Persons not affiliated with a social security scheme or beneficiaries of a similar scheme.
  • Persons who do not understand and do not speak French.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent

Bron, 69500, France

Location

CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent

Clermont-Ferrand, 63000, France

Location

CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent

Grenoble, 38043, France

Location

CHU de Saint-Etienne - Urgences psychiatriques

Saint-Etienne, 42100, France

Location

MeSH Terms

Conditions

Suicidal IdeationCOVID-19Suicide

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehaviorPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Multicenter descriptive study, involving retrospective data collection with a questionnaire and prospective qualitative evaluations. Research involving human subjects outside of health products as mentioned in Article L1121-1, 2° of the Public Health Code
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 24, 2025

First Posted

December 24, 2025

Study Start

December 1, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

December 24, 2025

Record last verified: 2025-11

Locations